Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 25

1.

Characterization of hematologic malignancies by flow cytometry.

Barlogie B, Latreille J, Freireich EJ, Fu CT, Mellard D, Meistrich M, Andreeff M.

Blood Cells. 1980;6(4):719-44.

PMID:
7008871
2.

Quantitative cytology in leukemia research.

Barlogie B, Maddox AM, Johnston DA, Raber MN, Drewinko B, Keating MJ, Freireich EJ.

Blood Cells. 1983;9(1):35-55. Review.

PMID:
6344934
3.

Clinical applications of flow cytometry.

Raber MN.

Oncology (Williston Park). 1988 Mar;2(3):35-43, 47. Review.

PMID:
3079323
4.

Detection of minimal residual disease (MRD) after bone marrow transplantation (BMT) by multi-parameter flow cytometry (MPFC).

Nagler A, Condiotti R, Rabinowitz R, Schlesinger M, Nguyen M, Terstappen LW.

Med Oncol. 1999 Sep;16(3):177-87. Review.

PMID:
10523797
5.

Characterization of hematologic malignancies by flow cytometry.

Barlogie B, McLaughlin P, Alexanian R.

Anal Quant Cytol Histol. 1987 May;9(2):147-55. Review.

PMID:
3300685
6.

Flow cytometry in the diagnosis of acute leukemia.

Weir EG, Borowitz MJ.

Semin Hematol. 2001 Apr;38(2):124-38. Review.

PMID:
11309694
8.

Stromal abnormalities in neoplastic bone marrow diseases.

Dührsen U, Hossfeld DK.

Ann Hematol. 1996 Aug;73(2):53-70. Review.

PMID:
8774614
9.

Immunophenotypic and DNA content characteristics of plasma cells in multiple myeloma and monoclonal gammopathy of undetermined significance.

Almeida J, Orfao A, Mateo G, Ocqueteau M, García-Sanz R, Moro MJ, Hernandez J, Ortega F, Borrego D, Barez A, Mejido M, San Miguel JF.

Pathol Biol (Paris). 1999 Feb;47(2):119-27. Review.

PMID:
10192879
10.
11.

[Magnetic resonance tomography of the bone marrow in malignant hematologic system diseases. A review with special reference to magnetic resonance tomographic techniques].

Schörner W, Hosten N, Neumann K, Huhn D, Felix R.

Rontgenpraxis. 1992 Jul;45(7):225-31. Review. German. No abstract available.

PMID:
1519118
12.

Detection of residual disease in acute leukemia using immunological markers.

Ryan DH, van Dongen JJ.

Cancer Treat Res. 1988;38:173-207. Review. No abstract available.

PMID:
2908595
13.

[The importance of bone marrow examination for hemoblastoses].

Döhner H, Ehrhardt R.

Radiologe. 1992 Oct;32(10):481-4. Review. German.

PMID:
1438716
14.

Flow cytometry and its application in small animal oncology.

Culmsee K, Nolte I.

Methods Cell Sci. 2002;24(1-3):49-54. Review.

PMID:
12815290
15.

Analytical cytometric approaches to heterogeneous cell populations in solid tumors: a review.

Dethlefsen LA, Bauer KD, Riley RM.

Cytometry. 1980 Sep;1(2):89-108. Review.

16.

The bony changes in malignant hematologic disease.

Van Slyck EJ.

Orthop Clin North Am. 1972 Nov;3(3):733-4. Review. No abstract available.

PMID:
4565586
17.

[The clinical significance of fluorocytometry of the cell cycle in acute lymphoblastic leukemias in children].

Demulder A, Ferster A, Fondu P.

Rev Med Brux. 1988 Oct;9(7-8):367-74. Review. French. No abstract available.

PMID:
3055136
18.

[DNA cell content in benign and malignant tumors of various sites].

Petrova AS, Bogatyrev VN.

Arkh Patol. 1986;48(4):86-90. Review. Russian.

PMID:
3521551
19.

Polychromatic flow cytometry in the clinical laboratory.

Sewell WA, Smith SA.

Pathology. 2011 Oct;43(6):580-91. doi: 10.1097/PAT.0b013e32834a69ae. Review.

PMID:
21881537
20.

Flow cytometry in clinical cancer research.

Barlogie B, Raber MN, Schumann J, Johnson TS, Drewinko B, Swartzendruber DE, Göhde W, Andreeff M, Freireich EJ.

Cancer Res. 1983 Sep;43(9):3982-97. Review. No abstract available.

Items per page

Supplemental Content

Write to the Help Desk